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Background: Currently >85% of children in the US with congenital heart disease (CHD) survive to adulthood. Patients with repaired Tetralogy 
of Fallot (TOF) and critical pulmonary stenosis (PS) frequently present with late sequelae including pulmonary insufficiency, right ventricular (RV) 
enlargement and systolic dysfunction. These patients may have left ventricular (LV) systolic dysfunction for no apparent cause. Prior studies have 
demonstrated improvement in RV size and function after pulmonary valve replacement (PVR); however changes in LV function post-PVR have rarely 
been described. We sought to determine the mid term results on LV function after PVR using cardiac magnetic resonance imaging (CMR).
Methods: Retrospective review of pts (≥16 years) from 1/1/06 to 7/1/11 was performed. Demographics, clinical variables, cardiopulmonary 
bypass (CPB) time and post-op medication use were reviewed. Pre and post-PVR CMR scans were analyzed for LV and RV volumes and ejection 
fraction (EF). Paired t-test was used to compare pre and post-PVR volumes and EF. Pearson linear correlation and multivariate analysis evaluated the 
effect of variables on LVEF.
Results: There were 40 pts who met inclusion criteria (TOF=29, PS=11). Mean age was 29±9 yrs (range:16-53). Each pt had a CMR before (173 
days±103) and after PVR (446 days±264). For the entire cohort, the mean LVEF increased from 54±8% to 57±6% (p = 0.023). Pre-PVR, 9 pts had 
depressed LVEF (44±5%, range 36-49%). In this group, the LVEF significantly increased post-PVR by 10±7% (p=.004). By multivariate analysis to 
assess CMR predictors for improved LVEF post-PVR, the only variable to emerge was low EF pre-PVR (regression coefficient:-.7,R2=.59, p<0.0001).
Demographics, clinical variables, medications, prior pregnancies and CPB time had no effect on LVEF post-PVR.
Conclusion: This is the largest CMR study to describe the mid-term results of LV function after PVR in adults with CHD. Patients with depressed 
LVEF pre-PVR had significant improvement in LV function post-PVR. Larger studies are needed to further evaluate predictors and pathophysiologic 
mechanisms associated with improved LVEF.
